GENETIC CHEMISTRY Trademark of Empress Therapeutics, Inc. - Serial Number 98327493

GENETIC CHEMISTRY Trademark

Trademark Overview

On Friday, December 22, 2023, a trademark application was filed for GENETIC CHEMISTRY with the United States Patent and Trademark Office. The USPTO has given the GENETIC CHEMISTRY trademark a serial number of 98327493. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Sunday, July 28, 2024. This trademark is owned by Empress Therapeutics, Inc.. The GENETIC CHEMISTRY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals; therapeutics; pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; pharmaceutical research and development; scientific and medical research and development; technical scientific consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and microbial products; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; drug discovery platform

General Information

Serial Number	98327493
Word Mark	GENETIC CHEMISTRY
Filing Date	Friday, December 22, 2023
Status	641 - NON-FINAL ACTION - MAILED
Status Date	Sunday, July 28, 2024
Registration Number	0000000
Registration Date	NOT AVAILABLE
Mark Drawing	4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition Date	NOT AVAILABLE

Trademark Statements

Goods and Services	Pharmaceuticals; therapeutics; pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; pharmaceutical research and development; scientific and medical research and development; technical scientific consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and microbial products; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; drug discovery platform
In Another Form Statement	The mark was first used anywhere in a different form other than that sought to be registered at least as early as
In Another Form Statement	The mark was first used anywhere in a different form other than that sought to be registered at least as early as

Classification Information

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	005, 006, 018, 044, 046, 051, 052
Class Status Code	6 - Active
Class Status Date	Wednesday, April 3, 2024
Primary Code	005
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

Party Name	Empress Therapeutics, Inc.
Party Type	10 - Original Applicant
Legal Entity Type	03 - Corporation
Address	Cambridge, MA 02142

Trademark Events

Event Date	Event Description
Friday, December 22, 2023	NEW APPLICATION ENTERED
Thursday, April 4, 2024	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 24, 2024	ASSIGNED TO EXAMINER
Sunday, July 28, 2024	NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, July 28, 2024	NON-FINAL ACTION E-MAILED
Sunday, July 28, 2024	NON-FINAL ACTION WRITTEN

Related Keywords

chemistry genetic development pharmaceuticals disorders diseases research field products microbial biotechnology biology